Genomic Testing Cooperative
Pre-clinicalTesting for all biomarkers of DNA & RNA (solid tumors & hematologic neoplasms). Revolutionary co-op model by Genomic Testing Cooperative.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $30M
About
Testing for all biomarkers of DNA & RNA (solid tumors & hematologic neoplasms). Revolutionary co-op model by Genomic Testing Cooperative.
Diagnostics
Funding History
2Total raised:$30M
Series B$20MMar 15, 2022
Series A$10MSep 15, 2020